SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-12-036030
Filing Date
2012-05-11
Accepted
2012-05-10 18:00:49
Documents
10
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a12-9286_110q.htm 10-Q 862945
2 EX-31.1 a12-9286_1ex31d1.htm EX-31.1 9914
3 EX-31.2 a12-9286_1ex31d2.htm EX-31.2 9902
4 EX-32.1 a12-9286_1ex32d1.htm EX-32.1 8374
  Complete submission text file 0001104659-12-036030.txt   3231923

Data Files

Seq Description Document Type Size
5 EX-101.INS fold-20120331.xml EX-101.INS 348682
6 EX-101.SCH fold-20120331.xsd EX-101.SCH 21954
7 EX-101.CAL fold-20120331_cal.xml EX-101.CAL 48963
8 EX-101.DEF fold-20120331_def.xml EX-101.DEF 101842
9 EX-101.LAB fold-20120331_lab.xml EX-101.LAB 328691
10 EX-101.PRE fold-20120331_pre.xml EX-101.PRE 147770
Mailing Address 6 CEDAR BROOK DRIVE CRANBURY NJ 08512
Business Address 6 CEDAR BROOK DRIVE CRANBURY NJ 08512 (609) 662-2000
AMICUS THERAPEUTICS INC (Filer) CIK: 0001178879 (see all company filings)

IRS No.: 200422823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33497 | Film No.: 12831649
SIC: 2834 Pharmaceutical Preparations